HCA Healthcare Inc. (HCA)
HCA Healthcare, Inc. (HCA) Healthcare, Inc. Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
HCA Healthcare, Inc. (NYSE:HCA ) Healthcare, Inc. Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 2:15 PM EDT Company Participants Mike Marks - CFO & Executive VP Conference Call Participants Stephen Baxter - Wells Fargo Securities, LLC, Research Division Presentation Stephen Baxter Senior Equity Analyst Alright. So good afternoon, everyone.
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Can HCA Healthcare Revive the Market's Weakest Sector?
The healthcare sector has experienced a 0.79% decline year-to-date, making it the worst performer among the S&P 500's 11 sectors and the only one in negative territory. But unlike other market-lagging sectors that have performed better of late (e.g.
HCA: This Healthcare Giant Will Not Make Your Portfolio Sick
HCA Healthcare is the best-managed U.S. hospital chain, offering essential services and resilient financials, making it a strong buy for diversified portfolios. Recent results show robust revenue and EPS growth, with aggressive share repurchases and manageable debt supporting shareholder returns. Valuation is attractive: a 16x multiple on 2025 EPS yields a $416 fair value, implying a 25% total return potential from current levels.
HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View
HCA Healthcare's Q2 earnings rose 24% year over year on stronger patient volumes. EPS for 2025 is expected to be within $25.5-$27, up from the earlier view of $24.05-$25.85.
HCA Healthcare (HCA) Beats Q2 Earnings and Revenue Estimates
HCA Healthcare (HCA) came out with quarterly earnings of $6.84 per share, beating the Zacks Consensus Estimate of $6.19 per share. This compares to earnings of $5.5 per share a year ago.
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Ahead of HCA (HCA) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top-and-bottom-line estimates for HCA (HCA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
